Article

Δ40 Isoform of p53 Controls β-Cell Proliferation and Glucose Homeostasis in Mice

Research Division, Joslin Diabetes Center and Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Diabetes (Impact Factor: 8.1). 02/2011; 60(4):1210-22. DOI: 10.2337/db09-1379
Source: PubMed

ABSTRACT

Investigating the dynamics of pancreatic β-cell mass is critical for developing strategies to treat both type 1 and type 2 diabetes. p53, a key regulator of the cell cycle and apoptosis, has mostly been a focus of investigation as a tumor suppressor. Although p53 alternative transcripts can modulate p53 activity, their functions are not fully understood. We hypothesized that β-cell proliferation and glucose homeostasis were controlled by Δ40p53, a p53 isoform lacking the transactivation domain of the full-length protein that modulates total p53 activity and regulates organ size and life span in mice.
We phenotyped metabolic parameters in Δ40p53 transgenic (p44tg) mice and used quantitative RT-PCR, Western blotting, and immunohistochemistry to examine β-cell proliferation.
Transgenic mice with an ectopic p53 gene encoding Δ40p53 developed hypoinsulinemia and glucose intolerance by 3 months of age, which worsened in older mice and led to overt diabetes and premature death from ∼14 months of age. Consistent with a dramatic decrease in β-cell mass and reduced β-cell proliferation, lower expression of cyclin D2 and pancreatic duodenal homeobox-1, two key regulators of proliferation, was observed, whereas expression of the cell cycle inhibitor p21, a p53 target gene, was increased.
These data indicate a significant and novel role for Δ40p53 in β-cell proliferation with implications for the development of age-dependent diabetes.

Download full-text

Full-text

Available from: Bernhard Fidelis Maier
    • "D133p53b has recently been shown to regulate cell stemness; however, its molecular mechanism is still unknown (Arsic et al. 2015). Over the past 10 years, using diverse human cell lines and animal models, all data have consistently indicated that the balance of expression among the p53 isoforms define the p53-mediat- ed cell response to trigger after damage, virus/ bacterial infection, or cell signals (Maier et al. 2004; Chen et al. 2009; Fujita et al. 2009; Medrano et al. 2009; Davidson et al. 2010; Pehar et al. 2010 Pehar et al. , 2014 Ungewitter and Scrable 2010; Aoubala et al. 2011; Hinault et al. 2011; Slatter Terrier et al. 2012; Wei et al. 2012; Bernard et al. 2013; Dichtel-Danjoy et al. 2013; Gambino et al. 2013; Mondal et al. 2013; Silden et al. 2013; Horikawa et al. 2014; Marcel et al. 2014; Takahashi et al. 2014; Arsic et al. 2015; Gong et al. 2015). The p53 isoforms thus play primordial roles in cell-cycle progression, programmed cell death, senescence, inflammation, stem-cell renewal and differentiation, aging, neurodegeneration, glucose metabolism, angiogenesis , embryo development, and cancer. "
    [Show abstract] [Hide abstract]
    ABSTRACT: It is poorly understood how a single protein, p53, can be responsive to so many stress signals and orchestrates very diverse cell responses to maintain/restore cell/tissue functions. The uncovering that TP53 gene physiologically expresses, in a tissue-dependent manner, several p53 splice variants (isoforms) provides an explanation to its pleiotropic biological activities. Here, we summarize a decade of research on p53 isoforms. The clinical studies and the diverse cellular and animal models of p53 isoforms (zebrafish, Drosophila, and mouse) lead us to realize that a p53-mediated cell response is, in fact, the sum of the intrinsic activities of the coexpressed p53 isoforms and that unbalancing expression of different p53 isoforms leads to cancer, premature aging, (neuro)degenerative diseases, inflammation, embryo malformations, or defects in tissue regeneration. Cracking the p53 isoforms' code is, thus, a necessary step to improve cancer treatment. It also opens new exciting perspectives in tissue regeneration.
    No preview · Article · Jan 2016 · Cold Spring Harbor Perspectives in Medicine
  • Source
    • "Mice carrying a p53 mutant that cannot be activated by ATM through phosphorylation develop insulin resistance and glucose intolerance, which are associated with a decreased antioxidant function (Armata et al., 2010). Mice that ectopically express D40p53, a p53 mutant that lacks part of the transactivation domain, also exhibit glucose intolerance, hypoinsulinemia, and defects in b cell mass and proliferation, suggesting that p53 plays a role in the regulation of b cell proliferation (Hinault et al., 2011). Conversely, super-p53 mice, which express an additional copy of normally regulated WT p53, have been found to display improved glucose tolerance (Franck et al., 2013). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The function of p53 is best understood in response to genotoxic stress, but increasing evidence suggests that p53 also plays a key role in the regulation of metabolic homeostasis. p53 and its family members directly influence various metabolic pathways, enabling cells to respond to metabolic stress. These functions are likely to be important for restraining the development of cancer but could also have a profound effect on the development of metabolic diseases, including diabetes. A better understanding of the metabolic functions of p53 family members may aid in the identification of therapeutic targets and reveal novel uses for p53-modulating drugs.
    Full-text · Article · Aug 2013 · Cell metabolism
  • Source
    • "Volume 3, Number 3, June 2012 265 miR-675 levels increase [102]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Aging is a process that involves all organs and tissues of the human organism. Cells and tissues are impacted by aging in differing degrees, depending on their regenerative potential and sensitivity to outside stimuli. In this review, we discuss the potential role of adult stem cells in the aging process, and the new results that support the role of stem cells in the aging process. Finally, we discuss new evidence from progeroid syndromes that supports the stem cell hypothesis of aging.
    Preview · Article · Jun 2012 · Aging and Disease
Show more